Annual Accounts Payable
$141.00 K
-$956.00 K-87.15%
31 December 2023
Summary:
Finch Therapeutics annual accounts payable is currently $141.00 thousand, with the most recent change of -$956.00 thousand (-87.15%) on 31 December 2023. During the last 3 years, it has fallen by -$2.48 million (-94.62%). FNCH annual accounts payable is now -96.23% below its all-time high of $3.74 million, reached on 31 December 2021.FNCH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$29.00 K
-$18.00 K-38.30%
30 June 2024
Summary:
Finch Therapeutics quarterly accounts payable is currently $29.00 thousand, with the most recent change of -$18.00 thousand (-38.30%) on 30 June 2024. Over the past year, it has dropped by -$328.00 thousand (-91.88%). FNCH quarterly accounts payable is now -99.39% below its all-time high of $4.76 million, reached on 31 March 2022.FNCH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.2% | -91.9% |
| 3 y3 years | -94.6% | -97.9% |
| 5 y5 years | - | - |
FNCH Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -96.2% | at low | -99.4% | at low |
| 5 y | 5 years | -96.2% | at low | -99.4% | at low |
| alltime | all time | -96.2% | at low | -99.4% | at low |
Finch Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $29.00 K(-38.3%) |
| Mar 2024 | - | $47.00 K(-66.7%) |
| Dec 2023 | $141.00 K(-87.1%) | $141.00 K(-60.5%) |
| Sept 2023 | - | $357.00 K(-17.4%) |
| June 2023 | - | $432.00 K(-83.1%) |
| Mar 2023 | - | $2.55 M(+132.7%) |
| Dec 2022 | $1.10 M | $1.10 M(+3.5%) |
| Sept 2022 | - | $1.06 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $1.01 M(-78.7%) |
| Mar 2022 | - | $4.76 M(+27.5%) |
| Dec 2021 | $3.74 M(+42.6%) | $3.74 M(+170.4%) |
| Sept 2021 | - | $1.38 M(-19.6%) |
| June 2021 | - | $1.72 M(-55.7%) |
| Mar 2021 | - | $3.88 M(+48.0%) |
| Dec 2020 | $2.62 M(+300.2%) | $2.62 M |
| Dec 2019 | $655.00 K | - |
FAQ
- What is Finch Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Finch Therapeutics?
- What is Finch Therapeutics annual accounts payable year-on-year change?
- What is Finch Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Finch Therapeutics?
- What is Finch Therapeutics quarterly accounts payable year-on-year change?
What is Finch Therapeutics annual accounts payable?
The current annual accounts payable of FNCH is $141.00 K
What is the all time high annual accounts payable for Finch Therapeutics?
Finch Therapeutics all-time high annual accounts payable is $3.74 M
What is Finch Therapeutics annual accounts payable year-on-year change?
Over the past year, FNCH annual accounts payable has changed by -$956.00 K (-87.15%)
What is Finch Therapeutics quarterly accounts payable?
The current quarterly accounts payable of FNCH is $29.00 K
What is the all time high quarterly accounts payable for Finch Therapeutics?
Finch Therapeutics all-time high quarterly accounts payable is $4.76 M
What is Finch Therapeutics quarterly accounts payable year-on-year change?
Over the past year, FNCH quarterly accounts payable has changed by -$328.00 K (-91.88%)